Correlation Between Molecular Partners and Precision BioSciences
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Precision BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Precision BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Precision BioSciences, you can compare the effects of market volatilities on Molecular Partners and Precision BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Precision BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Precision BioSciences.
Diversification Opportunities for Molecular Partners and Precision BioSciences
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Molecular and Precision is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Precision BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Precision BioSciences and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Precision BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Precision BioSciences has no effect on the direction of Molecular Partners i.e., Molecular Partners and Precision BioSciences go up and down completely randomly.
Pair Corralation between Molecular Partners and Precision BioSciences
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 1.54 times more return on investment than Precision BioSciences. However, Molecular Partners is 1.54 times more volatile than Precision BioSciences. It trades about 0.05 of its potential returns per unit of risk. Precision BioSciences is currently generating about -0.02 per unit of risk. If you would invest 448.00 in Molecular Partners AG on September 2, 2024 and sell it today you would earn a total of 134.00 from holding Molecular Partners AG or generate 29.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Precision BioSciences
Performance |
| Timeline |
| Molecular Partners |
| Precision BioSciences |
Molecular Partners and Precision BioSciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Precision BioSciences
The main advantage of trading using opposite Molecular Partners and Precision BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Precision BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precision BioSciences will offset losses from the drop in Precision BioSciences' long position.| Molecular Partners vs. Tff Pharmaceuticals | Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. Inhibrx | Molecular Partners vs. Enliven Therapeutics |
| Precision BioSciences vs. Tff Pharmaceuticals | Precision BioSciences vs. Eliem Therapeutics | Precision BioSciences vs. Inhibrx | Precision BioSciences vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |